133 related articles for article (PubMed ID: 1753716)
1. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.
Lamperth L; Dalakas MC; Dagani F; Anderson J; Ferrari R
Lab Invest; 1991 Dec; 65(6):742-51. PubMed ID: 1753716
[TBL] [Abstract][Full Text] [Related]
2. Histochemical and ultrastructural changes induced by zidovudine in mitochondria of rat cardiac muscle.
Corcuera Pindado MT; Lopez Bravo A; Martinez-Rodriguez R; Picazo Talavera A; Gomez Aguado F; Roldan Contreras M; Perez Alvarez MJ; Fernandez Garcia A; Alonso Martin MJ
Eur J Histochem; 1994; 38(4):311-8. PubMed ID: 7535128
[TBL] [Abstract][Full Text] [Related]
3. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
Semino-Mora MC; Leon-Monzon ME; Dalakas MC
Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879
[TBL] [Abstract][Full Text] [Related]
4. The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction.
Semino-Mora MC; Leon-Monzon ME; Dalakas MC
Lab Invest; 1994 Nov; 71(5):773-81. PubMed ID: 7967528
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
Zhu B; Zhu ZN; Wang JZ; Huang SM; Feng XM; Li AY; Yang DL; Wang BJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):794-7. PubMed ID: 23207344
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts.
Lewis W; Papoian T; Gonzalez B; Louie H; Kelly DP; Payne RM; Grody WW
Lab Invest; 1991 Aug; 65(2):228-36. PubMed ID: 1715447
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial sensitivity to AZT.
Pereira LF; Oliveira MB; Carnieri EG
Cell Biochem Funct; 1998 Sep; 16(3):173-81. PubMed ID: 9747509
[TBL] [Abstract][Full Text] [Related]
8. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
Gerschenson M; Erhart SW; Paik CY; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Quan W; Poirier MC
AIDS Res Hum Retroviruses; 2000 May; 16(7):635-44. PubMed ID: 10791874
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term zidovudine exposure on mitochondrial DNA content and succinate dehydrogenase activity of rat skeletal muscle cells.
Kiyomoto BH; Tengan CH; Godinho RO
J Neurol Sci; 2008 May; 268(1-2):33-9. PubMed ID: 18045616
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice.
Desai VG; Lee T; Moland CL; Branham WS; Von Tungeln LS; Beland FA; Fuscoe JC
Mitochondrion; 2009 Feb; 9(1):9-16. PubMed ID: 18824140
[TBL] [Abstract][Full Text] [Related]
11. Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.
Gerschenson M; Poirier MC
Ann N Y Acad Sci; 2000 Nov; 918():269-81. PubMed ID: 11131713
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.
Lewis W; Gonzalez B; Chomyn A; Papoian T
J Clin Invest; 1992 Apr; 89(4):1354-60. PubMed ID: 1556193
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells.
d'Amati G; Lewis W
Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833
[TBL] [Abstract][Full Text] [Related]
14. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
Herzberg NH; Zorn I; Zwart R; Portegies P; Bolhuis PA
Muscle Nerve; 1992 Jun; 15(6):706-10. PubMed ID: 1324428
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
18. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
Sinnwell TM; Sivakumar K; Soueidan S; Jay C; Frank JA; McLaughlin AC; Dalakas MC
J Clin Invest; 1995 Jul; 96(1):126-31. PubMed ID: 7615782
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus.
Waclawik AJ; Vann J; Schmelz G; Szurek P; Lewandoski P; Brooks BR
Neurotoxicology; 1999 Feb; 20(1):49-56. PubMed ID: 10091858
[TBL] [Abstract][Full Text] [Related]
20. Effect of zidovudine (AZT) on the structure and function of rat skeletal muscle.
Engbretson BG
Can J Physiol Pharmacol; 1996 Jun; 74(6):679-86. PubMed ID: 8909779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
